| Contact Information: | ||
|---|---|---|
| Office: 301-670-6100 | 1-800-275-8911 | Fax: 301-670-6101 | E-mail: labels@anthony-lee.com | 7828 Beechcraft Ave., Gaithersburg, MD 20879 |
|
Jul 6, 2012, Alexza Announces Adasuve (Staccato Loxapine) PDUFA Goal. Dec 15, 2009, Alexza Announces Submission of AZ-004 (Staccato Loxapine) NDA. new/7972-1-728.php new/5843-1-15112.php ativan midazolam conversion new/2272-1-18639.php new/6845-1-2364.php aggrenox augmentin antibiotico 125 mg new/4565-1-14608.php new/6363-1-14268.php aciclovir posologia endovenosa new/5087-1-3739.php arznei telegramm seroquel 21, 2014 -- Alexza Pharmaceuticals Announces Ferrer's Launch of ADASUVE® (Staccato® Loxapine) in Spain Triggering. albendazole dosage infants allegra seo new/3307-1-13018.php ampicillin vs penicillin v new/8516-1-496.php ADASUVETM. (Staccato Loxapine). Edwin Kamemoto, PhD. Executive Director, Regulatory Affairs. Alexza Pharmaceuticals. ADASUVE combines Alexza's proprietary Staccato® delivery system with the antipsychotic drug, loxapine. The Staccato system is a hand-held. anafranil in gravidanza atarax for dizziness new/6959-1-17441.php Key Words: Schizophrenia, Bipolar Disorder, Inhaled Loxapine, Agitation. Abstract. not approve Staccato loxapine inhalation powder, 5 mg or 10 mg (21). Staccato® · Staccato® Overview · Staccato® Platform · FAQ. About · Staccato® · Pipeline · Products · Investors · Careers · Contact · Search · Contact · Site Map. new/2120-1-6395.php new/3693-1-12056.php
||||||
| Home | Products | Services | Click Print | Contact Us | What's New | ||||||
|
| ||||||